MedTrace Logo

The Compliance of DAPT and Statins on Clinical Outcomes in Percutaneous Coronary Intervention Patients

NCT03785509 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 47291

Last updated 2018-12-24

No results posted yet for this study

Summary

A nationwide retrospective cohort study. To investigate the real world medication compliance and the relation with clinical outcomes.

The persistence and compliance to dual anti-platelet therapy(DAPT) and dyslipidemia agents are important for the patients undergoing percutaneous coronary intervention. But, the discontinuation and compliance rate are unknown in the real world setting.

Conditions

  • Platelet Aggregation Inhibitors
  • Hydroxymethylglutaryl-coa Reductase Inhibitors
  • Compliance, Medication
  • Adherence, Medication
  • Persistence, Medication
  • Percutaneous Coronary Intervention

Interventions

DRUG

DAPT, Statin

Compliance of DATP, Compliance of Statin, Drug Eluting Stent, Bare Metal Stent

Sponsors & Collaborators

  • Samsung Medical Center

    lead OTHER

Principal Investigators

  • Jin-Ho Choi, MD, PhD · Samsung Medical Center

Eligibility

Sex
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-04-06
Primary Completion
2018-02-06
Completion
2018-11-30

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03785509 on ClinicalTrials.gov